Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Satsuma Pharmaceuticals
Biotech
With skin in the game, Satsuma's partner offers buyout
The Japanese company behind the tech used to deliver Satsuma's migraine spray has stepped in to keep the dream alive.
James Waldron
Apr 17, 2023 8:31am
Satsuma peels off staff, cutting head count by 36% to save cash
Mar 29, 2023 6:30am
Satsuma in the red after migraine candidate fails phase 3 again
Nov 14, 2022 9:15am
Phase 3 migraine flop squashes Satsuma's stock price
Sep 11, 2020 8:20am
